Updated Jul 16, 2026
Duncan Charles Cliff has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Duncan Charles Cliff is associated with Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies to address unmet medical needs. Specific details about his role and contributions at the company are not widely documented.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-08 | VNDA | Vanda Pharmaceuticals Inc. | A — Grant or award | 41.6K | $0.00 | |
| 2026-04-24 | VNDA | Vanda Pharmaceuticals Inc. | A — Grant or award | 57.1K | $0.00 |
Duncan Charles Cliff is associated with Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies to address unmet medical needs. Specific details about his role and contributions at the company are not widely documented.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Duncan Charles Cliff profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.